Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma

specific

A mature T-cell and NK-cell non-Hodgkin lymphoma that is resistant to treatment.

32

Centers

34

Active Trials

Cancer Funding

Top Centers for Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma(32)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Clinical
High-Volume Research Center
73.4
2
NCI Comprehensive
Active Research Program
69.1
3
NCI Comprehensive
Active Research Program
69.1
4
NCI Comprehensive
Active Research Program
69.1
5
Active Research Program
69.1
6
Active Research Program
69.1
7
NCI Comprehensive
Active Research Program
50.9
8
NCI Comprehensive
Active Research Program
50.9
9
NCI Comprehensive
Active Research Program
50.9
10
NCI Comprehensive
Active Research Program
50.9
11
NCI Comprehensive
Active Research Program
50.9
12
NCI Comprehensive
Active Research Program
50.9
13
NCI Comprehensive
Active Research Program
50.9
14
NCI Comprehensive
Active Research Program
50.9
1550.9
16
NCI Comprehensive
Active Research Program
50.9
17
NCI Comprehensive
Active Research Program
50.9
18
NCI Comprehensive
Active Research Program
50.9
19
NCI Comprehensive
Active Research Program
50.9
20
NCI Comprehensive
Active Research Program
50.9
21
NCI Comprehensive
Active Research Program
50.9
22
NCI Clinical
Active Research Program
50.9
23
NCI Comprehensive
Active Research Program
50.9
24
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
50.9
25
Active Research Program
50.9
26
Active Research Program
50.9
27
BC CancerVancouver, BC
Active Research Program
50.9
28
NCI Comprehensive
32.6
29
NCI Comprehensive
32.6
3032.6
31
NCI Comprehensive
32.6
3232.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →